Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GenScript Biotech Reports Full Year 2020 Financial Results and Business Results 2021-03-30 01:35
Tigermed Reports 2020 Annual Results With Solid Growth 2021-03-29 21:21
Getinge introduces a long-term flexible workplace approach 2021-03-29 15:40
Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint 2021-03-29 08:27
Making Most out of Launched Products Fueling Diversified Innovation through Integrated Platform 2021-03-28 11:16
Genscript Biotech Reports Full Year 2020 Financial Results 2021-03-27 02:16
Kintor Pharmaceutical Limited Announces 2020 Business Progress and Annual Results 2021-03-26 20:54
Ascentage Pharma Announces Publication of Preclinical Data in Nature Immunology Showing Enhanced T-Cell-Mediated Antitumor Immunity Induced by Its MDM2-p53 Inhibitor APG-115 2021-03-26 08:38
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion 2021-03-26 08:00
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round 2021-03-26 05:19
Antengene Appoints Kevin Lynch as Chief Medical Officer 2021-03-25 23:26
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine 2021-03-25 21:00
AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine 2021-03-25 17:00
GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development 2021-03-25 16:35
Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell Therapies 2021-03-24 22:01
Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation 2021-03-24 19:07
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate 2021-03-24 14:18
CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients 2021-03-24 10:46
Transcenta Announces Appointments of Dr. Xichen Zhang as Senior Vice President of Manufacturing and Dr. Steven Yu as Senior Vice President of DMPK and Translational Science 2021-03-24 08:00
Dr. Cheng-Chi Chao joins ChemPartner as Vice President and Head of Immunotherapy and Inflammation 2021-03-24 00:02
1 252 253 254 255 256 451